MLK4 regulation of MAPK signaling
MLK4 regulation of MAPK signaling
批准号:
8366331
负责人:
Deborah N Chadee
金额:
$34.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2016-08-31
关键词:
AffectBindingBiochemicalBiologicalBiological AssayBiological ProcessCell ProliferationCellsCo-ImmunoprecipitationsDevelopmentEGF geneFamilyIn VitroMAP Kinase Kinase KinaseMAP Kinase Signaling PathwaysMAP kinase activatorMAPK8 geneMatrix MetalloproteinasesMitogen-Activated Protein KinasesNormal CellPathway interactionsPhosphorylationPhosphotransferasesProtein IsoformsRNA SplicingRegulationRoleSignal PathwaySignal TransductionTNF geneTestingTumor Cell Invasioncancer therapydesigninsightmalignant phenotypemetaplastic cell transformationmigrationmitogen-activated protein kinase p38mutantneoplastic cellnoveloverexpressionresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Mixed Lineage Kinases (MLKs) are a family of mitogen-activated protein (MAP) kinase kinase kinases (MAP3Ks) that activate multiple MAP kinase (MAPK) signaling pathways to elicit specific cellular responses. The MLK subfamily consists of MLKs 1, 2, 3, 4 and 4. Of these, MLK3 has been the best characterized in terms of biological function and biochemical activity. MLK3 activates ERK, JNK and p38 MAPK pathways and has important functions in cell proliferation and tumor cell invasion. In contrast, very little is known about the biological functon and biochemical activity of MLK4, for which there are two alternatively spliced isoforms. Our preliminary results suggest that MLK4 does not function as a typical MAPK in promoting activation of MAPK signaling pathways. Instead MLK4 is a negative regulator of MAPK signaling and tumor cell invasion. Furthermore, we have identified a novel interaction between MLK4 and MLK3, and we propose that MLK4 suppresses MAPK signaling and invasion by directly inhibiting MLK3 activation. The experiments described in this proposal are designed to investigate the function of MLK4 in regulating MLK3 activation, MAPK signaling and tumor cell invasion. Accordingly, the specific aims of this proposal are as follows: (1) To analyze the role o MLK4 in regulating MAPK signaling. In vitro kinase assays will be performed to test if MLK4 has activity towards MAP2Ks, and if MLK4 inhibits the activity of other MAP3Ks in addition to MLK3. (2) To investigate the MLK3-MLK4 interaction and the mechanism by which MLK4 inhibits MLK3 activation. In vitro binding assays will be performed with MLK4 and MLK3 deletion mutants to identify the regions of MLK3 and MLK4 that interact. Co-immunoprecipitations will be performed in cells overexpressing MLK4 to determine if MLK4 inhibits the MLK3-TRAF, MLK3-Cdc42 or MLK3-B-Raf interactions. (3) To investigate the function of MLK4 in tumor cell proliferation and invasion. Cell proliferation assays and invasion assays (using a modified Boyden chamber) will be performed to test if MLK4 expression or knockdown affects cell proliferation or invasion. The results from the proposed studies will broaden our understanding of the different roles of MLKs in cell signaling and tumor cell invasion, which could provide insight into how altered MLK activity may contribute to establishment of the malignant phenotype.
PUBLIC HEALTH RELEVANCE:
MAPK signaling pathways have a central role in the regulation of numerous cellular responses such as proliferation, differentiation, migration and invasion. Since persistent activation of MAPK
signaling is a major contributor to the establishment of a malignant phenotype, a thorough understanding of how MAPK pathways are tightly controlled by both positive and negative regulatory factors is essential to the development of novel cancer therapies.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/onc.2017.396
发表时间:
2018-02-22
期刊:
Oncogene
影响因子:
8
作者:
[Schroyer AL, Stimes NW, Abi Saab WF, Chadee DN]
通讯作者:
Chadee DN
DOI:
10.1016/j.cellsig.2017.07.021
发表时间:
2017-11
期刊:
Cellular signalling
影响因子:
4.8
作者:
[Blessing NA, Kasturirangan S, Zink EM, Schroyer AL, Chadee DN]
通讯作者:
Chadee DN
Regulation of Cadherins by MLK3
-
批准号:10793060
-
项目类别:
-
资助金额:$45.15万
-
财政年份:2023
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of MLK3 by LATS
-
批准号:10056321
-
项目类别:
-
资助金额:$15.81万
-
财政年份:2019
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of MLK3 by LATS
-
批准号:9811718
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2019
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of MLK3 by oxidative stress in colon cancer cells
-
批准号:9097305
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2016
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of Mixed Lineage Kinase 3 by the tumor suppressor protein Merlin
-
批准号:7364459
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2008
-
负责人:Deborah N Chadee
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: